[HTML][HTML] Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection
Background Patients who are chronically infected with hepatitis C virus (HCV) and who do
not have a sustained virologic response after treatment with regimens containing direct-acting …
not have a sustained virologic response after treatment with regimens containing direct-acting …
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda
Background: Little is known about the effect of combination antiretroviral therapy (cART) on
life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once …
life expectancy in sub-Saharan Africa. Objective: To estimate life expectancy of patients once …
CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults
CL Cooper, HL Davis, JB Angel, ML Morris, SM Elfer… - Aids, 2005 - journals.lww.com
Background: HIV patients are vaccine hyporesponsive. Methods: We evaluated CPG 7909,
a synthetic oligodeoxynucleotide containing immunostimulatory CpG motifs, as an adjuvant …
a synthetic oligodeoxynucleotide containing immunostimulatory CpG motifs, as an adjuvant …
Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review
FR Domingo, LA Waddell, AM Cheung, CL Cooper… - MedRxiv, 2021 - medrxiv.org
Objective Post COVID-19 condition refers to persisting or recurring symptoms weeks after
acute COVID-19 illness which can significantly impact quality of life and health systems. It is …
acute COVID-19 illness which can significantly impact quality of life and health systems. It is …
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Background: In Canada, interferon-free, direct-acting antiviral hepatitis C virus (HCV) regimens
are costly. This presents challenges for universal drug coverage of the estimated 220 …
are costly. This presents challenges for universal drug coverage of the estimated 220 …
Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and …
Background. A systematic review and meta-analysis were conducted to examine the efficacy
and safety of pegylated interferon (peg-IFN) alfa-2a and peg-IFN alfa-2b plus ribavirin (RBV…
and safety of pegylated interferon (peg-IFN) alfa-2a and peg-IFN alfa-2b plus ribavirin (RBV…
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response
…, ML Morris, MJ AlAdhami, DW Cameron, CL Cooper… - Vaccine, 2004 - Elsevier
We assessed the avidity maturation process elicited by human immunization with alum-adsorbed
HBsAg alone or with a novel adjuvant containing CpG motifs (CpG 7909). Mean avidity …
HBsAg alone or with a novel adjuvant containing CpG motifs (CpG 7909). Mean avidity …
Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and …
…, SK Fung, F Alvarez, CL Cooper… - Canadian Liver …, 2018 - canlivj.utpjournals.press
Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …
[HTML][HTML] Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV
C Chambers, H Samji, CL Cooper, CT Costiniuk… - AIDS, 2022 - journals.lww.com
Objective: People with HIV were underrepresented in coronavirus disease 2019 (COVID-19)
vaccine clinical trials. We estimated vaccine effectiveness (VE) against severe acute …
vaccine clinical trials. We estimated vaccine effectiveness (VE) against severe acute …
[HTML][HTML] Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8+ T-Cells in Advanced Liver Disease
…, F Deonarine, S Kaka, JB Angel, CL Cooper… - Frontiers in …, 2019 - frontiersin.org
Chronic hepatitis C virus (HCV) infection disrupts immune functions, including that of cytotoxic
CD8 + T-cells which are important mediators of immune response. While HCV cure aims …
CD8 + T-cells which are important mediators of immune response. While HCV cure aims …